News

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...
The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...
Jay Bhattacharya is director of the National Institutes of Health.
The list seems to have been used as research for the 2024 book, "Toxic Shot: Facing the Dangers of the COVID 'Vaccines.'" The ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.
RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...
Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.
In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...